Loading...

Hikma Pharmaceuticals PLC

HKMPF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$18.00
$0.70(4.08%)
U.S. Market opens in 14h 21m

Hikma Pharmaceuticals PLC (HKMPF) Stock Overview

Explore Hikma Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio9.83
EPS (TTM)$1.81
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$17.83
3 Months$16.82
1 Year Target$19.87

HKMPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hikma Pharmaceuticals PLC (HKMPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.83 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.08%
5-Day Change
4.05%
1-Month Change
9.76%
3-Month Change
-13.42%
6-Month Change
-24.94%
Year-to-Date (YTD) Change
-14.04%
1-Year Change
-31.30%
3-Year Change
-12.79%
5-Year Change
-45.45%
All-Time (Max) Change
205.08%

Contact Information

https://www.hikma.com
44 20 7399 2760
1 New Burlington Place, London, NaN, W1S 2HR

Company Facts

9,500 Employees
IPO DateAug 22, 2012
CountryGB
Actively Trading

Frequently Asked Questions